CVS Health Product — Revenue increased by 3.8% to $67.04B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $61.91B to $67.04B. Over 4 years (FY 2021 to FY 2025), Product — Revenue shows an upward trend with a 5.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests higher retail traffic, successful pricing strategies, or increased volume in prescription fulfillment, while a decrease may indicate competitive pressure, shifts in consumer behavior, or changes in pharmacy benefit management reimbursement models.
This metric represents the total gross sales generated from the sale of pharmaceutical products, over-the-counter health...
Comparable to retail pharmacy revenue segments at major drugstore chains or the retail product divisions of diversified healthcare conglomerates.
cvs_segment_products_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $50.53B | $51.85B | $53.97B | $52.52B | $56.79B | $57.64B | $59.66B | $58.15B | $60.54B | $61.30B | $65.15B | $53.72B | $56.21B | $59.67B | $61.91B | $57.67B | $60.61B | $64.59B | $67.04B |
| QoQ Change | — | +2.6% | +4.1% | -2.7% | +8.1% | +1.5% | +3.5% | -2.5% | +4.1% | +1.3% | +6.3% | -17.5% | +4.6% | +6.2% | +3.7% | -6.9% | +5.1% | +6.6% | +3.8% |
| YoY Change | — | — | — | — | +12.4% | +11.2% | +10.5% | +10.7% | +6.6% | +6.3% | +9.2% | -7.6% | -7.1% | -2.6% | -5.0% | +7.3% | +7.8% | +8.2% | +8.3% |